Immunogenomics Market Report 2026

Immunogenomics Market Overview

• Immunogenomics market size has reached to $6.09 billion in 2025 • Expected to grow to $12.73 billion in 2030 at a compound annual growth rate (CAGR) of 15.8% • Growth Driver: Increasing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Transmission And Need For Personalized Immune-Based Solutions • Market Trend: Advancements in Artificial Intelligence-Based Immunogenomics And Vaccine Design • North America was the largest region in 2025.

What Is Covered Under Immunogenomics Market?

Immunogenomics is the branch of genomics that studies how an individual’s genetic makeup influences the functioning of their immune system. It focuses on understanding genetic variations that affect immune responses, susceptibility to infections and autoimmune diseases, and the effectiveness of immunotherapies and vaccines. The main product types of immunogenomics are instruments, consumables, software, and services. Instruments in immunogenomics are laboratory devices used to analyze genetic material and study the immune system, including sequencers, microarray scanners, and cell sorters. The technologies employed include next-generation sequencing, microarray, polymerase chain reaction, and others. Its applications cover oncology, infectious diseases, autoimmune disorders, transplantation, and others, serving end-users including hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and others.

What Is The Immunogenomics Market Growth Forecast?

The immunogenomics market size is expected to see rapid growth in the next few years. It will grow to $12.73 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to increasing demand for precision medicine solutions, rising development of personalized vaccines and immunotherapies, expansion of translational immunogenomics research, growing integration of multi-omics data, increased adoption of cloud-based genomic analytics. Major trends in the forecast period include increasing adoption of next-generation sequencing in immune profiling, rising use of bioinformatics tools for immune data analysis, growing focus on personalized immunotherapies, expansion of genomic databases for immune research, enhanced integration of ai in immunogenomic studies.

Global Immunogenomics Market Segmentation

1) By Product Type: Instruments, Consumables, Software, Services 2) By Technology: Next-Generation Sequencing, Microarray, Polymerase Chain Reaction, Other Technologies 3) By Application: Oncology, Infectious Diseases, Autoimmune Disorders, Transplantation, Other Applications 4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments: 1) By Instruments: Sequencers, Microarray scanners, Flow cytometers 2) By Consumables: Reagents, Kits, Assay panels 3) By Software: Data analysis software, Bioinformatics tools, Visualization platforms 4) By Services: Sequencing services, Genomic profiling, Bioinformatics support

What Is The Driver Of The Immunogenomics Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the immunogenomics market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person to another. The rising prevalence of infectious diseases is due to increased travel, which facilitates the rapid spread of pathogens across borders. Immunogenomics enhances infectious disease management by enabling precise analysis of host immune responses and genetic susceptibility. It reduces trial-and-error in treatment by identifying patient-specific immune factors, improving diagnostics, vaccine development, and personalized therapeutic strategies. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the immunogenomics industry.

Key Players In The Global Immunogenomics Market

Major companies operating in the immunogenomics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., BGI Group, GenScript Biotech Corporation, CareDx Inc., Oxford Nanopore Technologies plc, Genewiz LLC, Adaptive Biotechnologies Corporation, GenomOncology LLC, Personalis Inc., Variantyx Inc., CD Genomics Inc., Sengenics Corporation, GeneCentric Therapeutics Inc., Immunogenomics Inc., ImmuQuad Biotechnologies Inc., Neomics Pharmaceuticals LLC, Yemaachi Biotech Ltd., BioAnalytica Biotechnology Systems Inc.

Global Immunogenomics Market Trends and Insights

Major companies operating in the immunogenomics market are focusing on developing advanced solutions, such as a vaccine target prediction system, which allows for automated end-to-end vaccine design and optimizes vaccine constructs by ensuring optimal antigen sequence. The vaccine target prediction system is a computational platform that uses bioinformatics algorithms along with genomic and immunomic data to identify putative antigen molecules from pathogens or cancer cells and analyzes structural properties to prioritize and select optimal vaccine candidates with the highest potential to elicit protective immune responses. For instance, in September 2024, Evaxion Biotech A/S, a Denmark-based biotechnology company that specializes in artificial intelligence-driven immunotherapy and vaccine development, launched the clinically validated AI-Immunology platform, an upgraded EDEN artificial intelligence prediction model that includes a novel toxin antigen predictor that improves the accuracy and reliability of bacterial toxin antigen identification for next-generation bacterial vaccine development. Additionally, the platform simulates the immune system to create personalized and next-generation immunotherapies and has demonstrated strong correlations between artificial intelligence-generated predictions and clinical outcomes.

What Are Latest Mergers And Acquisitions In The Immunogenomics Market?

In January 2025, Adaptive Biotechnologies Corp., a US-based biotechnology company, partnered with NeoGenomics Laboratories Inc. to enhance advanced immunogenomic testing services. This partnership aims to broaden access to personalized minimal residual disease (MRD) monitoring for blood cancer patients, supporting tailored treatment approaches and improved patient care through the integration of state-of-the-art sequencing and diagnostic technologies. NeoGenomics Laboratories Inc. is a US-based testing company that specializes in providing immunogenomics testing services.

Regional Outlook

North America was the largest region in the immunogenomics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Immunogenomics Market?

The immunogenomics market also consists of revenues earned by entities by providing services such as immune profiling, bioinformatics analysis, biomarker discovery, and immunotherapy support. The market value includes the value of related goods sold by the service provider or included within the service offering. The immunogenomics market also includes sales of sequencing kits, reagents, microarrays, and bioinformatics tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Immunogenomics Market Report 2026?

The immunogenomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the immunogenomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.